Search Science Hub

Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.

Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

ECO 2026 12 - 15 May 2026

Early Responders to Oral Semaglutide 25 mg: A Post Hoc Analysis of the OASIS 4 Trial

Authors :

W. Timothy Garvey¹; Oscar Birkhan²; Naveen Rathor²; Chaithra Shaji³; Domenica Rubino⁴

Affiliations

View Details Hide Details

Download .PDF

Keywords

Obesity

Congress poster

GLP-1 RA

Semaglutide (oral)

PHASE 3 (RCT)